Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia

NCT01902602 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2020-03-16

No results posted yet for this study

Summary

The objective of this clinical study is to evaluate the influence of the Great autohemotherapy with oxygen-ozone (hyperbaric ozone therapy ) to describe the cardiovascular system in patients with resistant hypertension. The primary endpoint is the change in mean blood pressure after 10 treatments .

In addition, data are collected on the immune system as well as for food and sleep quality.

Conditions

  • Hypertonia

Sponsors & Collaborators

  • Herrmann Apparatebau GmbH

    lead INDUSTRY

Principal Investigators

  • Panos Porikis, Phd · unafflicated

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-03-31
Completion
2016-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01902602 on ClinicalTrials.gov